The Hong Kong Institute of Biotechnology Limited (HKIB) is a leading organization dedicated to the advancement of biotechnology and Chinese medicine (CM) industries in Hong Kong. Established in 1988 by the Council of the Chinese University of Hong Kong (CUHK), HKIB has been instrumental in providing catalyst and essential infrastructure for research and development in these fields. With extensive grants from the Innovation & Technology Commission (ITC), HKIB has made significant progress in research, GMP production, and technology development.

The institute offers a wide range of services including infrastructure support, product and technology development, contract manufacturing, Good Manufacturing Practice (GMP) consultation, and training. As a trusted partner, HKIB collaborates with industrial partners to bring cutting-edge technology and product development in biotechnology, pharmaceuticals, and CM. Being affiliated with CUHK and a designated local public research institute of the ITC, HKIB plays a crucial role in fostering collaboration among academia, government, and industry.

Operating on a cost-recovery basis, HKIB is committed to transforming research results into viable commercial products. Join us in revolutionizing the future of biotechnology and CM in Hong Kong